To identify unique mechanisms of immune cell recruitment to the brain and determine if inhibiting immune cells from infiltrating the brain attenuates cachexia, we treated OT-implanted tumor-bearing mice with either a CCR2 inhibitor (RS504393, Tocris) or CXCR2 inhibitor (SB225002, Tocris). Here, CCR2 is linked to neoplasm.